-
COMPARATIVE EFFICACY OF BUDESONIDE/GLYCOPYRRONIUM/FORMOTEROL FUMARATE VERSUS BECLOMETHASONE DIPROPIONATE/GLYCOPYRRONIUM/FORMOTEROL FUMARATE IN UNCONTROLLED ASTHMA: A MATCHING ADJUSTED INDIRECT COMPARISON (MAIC)
Aug 11, 2026, 17:16 PM -
BENCHMARKING IMPOWER133 AND EXTENDING EVIDENCE TO ECOG PS2 PATIENTS USING A REGISTRY-BASED TARGET TRIAL EMULATION
Aug 11, 2026, 17:16 PM -
FOUNDATIONS BEFORE INTEGRATION: STAKEHOLDER PRIORITIES FOR HTA DEVELOPMENT IN SLOVENIA IN THE ERA OF THE EU HTA REGULATION
Aug 11, 2026, 17:16 PM -
ECONOMIC MODEL ARCHITECTURE IN NICE EVALUATIONS FOR ULTRA-RARE NON-ONCOLOGY CONDITIONS: A COMPARATIVE ANALYSIS OF STRUCTURAL CHOICES AND CLINICAL TRIAL ENDPOINT USE ACROSS THE STA AND HST PATHWAYS
Aug 11, 2026, 17:16 PM -
PAVE-MA: A STANDARDIZED, LOCALLY SOURCED PROTOCOL FOR AREA-BY-AREA ECONOMIC EVALUATION OF PREVENTION IN MOROCCO
Aug 11, 2026, 17:16 PM -
IMPACT OF COMPARATOR SELECTION BASED ON SEQUENTIAL ANALYSIS ON COST-EFFECTIVENESS CONCLUSIONS IN CDA-AMC REIMBURSEMENT RECOMMENDATIONS
Aug 11, 2026, 17:16 PM -
COMPARATIVE VALIDATION OF SURVIVAL EXTRAPOLATION USING PARAMETRIC MODELS FOR HEALTH ECONOMIC EVALUATIONS
Aug 11, 2026, 17:16 PM -
WHAT THE FIRST COMPLETED EU JOINT CLINICAL ASSESSMENT DOES NOT TELL US: A STRUCTURED ANALYSIS OF THE TOVORAFENIB JCA AND REMAINING METHODOLOGICAL UNCERTAINTIES
Aug 11, 2026, 17:16 PM -
CLINICAL AND ECONOMICAL BURDEN OF CHRONIC SEDATIVE-HYPNOTIC USE FOR INSOMNIA DISORDER: A NATIONWIDE FRENCH CLAIMS DATABASE STUDY
Aug 11, 2026, 17:16 PM -
INDOLENT SYSTEMIC MASTOCYTOSIS IN FRANCE: A FIRST ESTIMATION OF THE ANNUAL MEDICAL AND SOCIOECONOMIC BURDEN
Aug 11, 2026, 17:16 PM -
ESTIMATING THE ECONOMIC BURDEN OF PRE-TRANSPLANT HEMODIALYSIS FOR KIDNEY TRANSPLANT RECIPIENTS IN BRAZIL: INSIGHTS FROM REAL-WORLD DATA
Aug 11, 2026, 17:16 PM -
CLINICAL PRESENTATION, DIAGNOSTIC UTILIZATION, AND CLINICAL BURDEN IN BING-NEEL SYNDROME: A SYSTEMATIC REVIEW OF PUBLISHED CASE REPORTS
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF SINGLE INHALER BUDESONIDE/GLYCOPYRRONIUM/FORMOTEROL FUMARATE DIHYDRATE VERSUS DUAL THERAPY ICS/LABA IN UNCONTROLLED ASTHMA: A UK PERSPECTIVE
Aug 11, 2026, 17:16 PM -
REAL-WORLD EVIDENCE TO ASSESS THE FEASIBILITY OF LOW-DOSE CT LUNG CANCER SCREENING IN THE BRAZILIAN UNIFIED HEALTH SYSTEM (SUS)
Aug 11, 2026, 17:16 PM -
BURDEN OF RESTRICTED AND INEQUITABLE ACCESS IN RARE DISEASE: GLOBAL EFFECTS (BRIDGE) STUDY
Aug 11, 2026, 17:16 PM -
SENTINEL EVENTS AND FATAL ADVERSE OUTCOMES IN ROMANIAN HOSPITALS: AN EIGHT-YEAR NATIONAL REVIEW (2017-2024)
Aug 11, 2026, 17:16 PM -
HEALTHCARE RESOURCE UTILIZATION AND COSTS OF CHRONIC KIDNEY DISEASE IN SPAIN: A 10-YEAR POPULATION-BASED REAL-WORLD ANALYSIS OF TRENDS AND ECONOMIC BURDEN
Aug 11, 2026, 17:16 PM -
OUT-OF-POCKET CATASTROPHIC HEALTH EXPENDITURE ATTRIBUTABLE TO CANCER CARE IN INDIA: A NATIONALLY REPRESENTATIVE HOUSEHOLD-LEVEL ANALYSIS OF THE NSS 75TH ROUND HEALTH SURVEY
Aug 11, 2026, 17:16 PM -
EVALUATING THE ECONOMIC IMPACT AND DIAGNOSTIC EFFICIENCY OF PLASMA PTAU217 TESTING IN THE UK NHS ALZHEIMER'S DISEASE PATHWAY
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS ANALYSIS OF THE TWENTY-VALENT PNEUMOCOCCAL CONJUGATE VACCINE AGAINST THE THIRTEEN-VALENT PNEUMOCOCCAL CONJUGATE VACCINE FOR PAEDIATRIC VACCINATIONS IN MOROCCO FROM THE PUBLIC HEALTHCARE PAYER PERSPECTIVE
Aug 11, 2026, 17:16 PM
